ArticleJournal of biological engineering2026
Optimizing 3D-printed core-shell hydrogel system for probiotic protection: stability under in vitro digestion conditions and during storage.
Article in Journal of biological engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study aimed to develop a novel pH-sensitive core-shell delivery system to improve probiotics' viability during simulated digestion and storage. A 10-strain premix of Lactobacillus and Bifidobacterium was encapsulated within a pregelatinized starch-based gel core, while alginate/pectin (Al/P) gel was employed as the shell using a 3D food printing (3DFOODP) process. The survival rates indicated that the 3DFOODP process did not compromise probiotic viability. To evaluate efficacy, a long-term storage stability study was conducted over a 33-day period under 4 °C and 23 °C, and at 50 °C for 2 h. Storage at 4 °C was most favorable, maintaining a survival rate of 64.37% after 33 days. In contrast, unencapsulated probiotics exhibited significantly reduced viability, falling below 5% by day 18 at 4 °C (3.55%) and by day 15 at 23 °C (2.75%), and reaching negligible survival by the end of the 33-day storage period. Under simulated digestion, the retention of encapsulated probiotics was 97.22% in the oral phase, 83.33% under gastric conditions, and 82.70% in the intestinal phase. Conversely, unencapsulated probiotics showed 93.62%, 10.92%, and 6.30% retention, respectively. These findings provided strong evidence supporting the protective function of the core-shell gel system, thereby facilitating the targeted functionality and colonization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.